FMR LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 53 filers reported holding SPERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6
-99.8%
4
-99.9%
0.00%
Q2 2022$3,000
+200.0%
4,120
+3900.0%
0.00%
Q1 2022$1,000
-99.2%
103
-98.8%
0.00%
Q1 2021$126,000
-24.1%
8,5520.0%0.00%
Q4 2020$166,000
+38.3%
8,552
-20.5%
0.00%
Q3 2020$120,000
-78.7%
10,752
-74.2%
0.00%
Q2 2020$564,000
-29.5%
41,652
-57.9%
0.00%
Q1 2020$800,000
-15.9%
98,9520.0%0.00%
Q4 2019$951,000
-47.4%
98,952
-42.0%
0.00%
Q3 2019$1,808,000
-31.4%
170,588
-25.5%
0.00%
Q2 2019$2,635,000
-47.2%
228,952
-41.2%
0.00%
-100.0%
Q1 2019$4,986,000
+65.9%
389,252
-20.3%
0.00%
Q4 2018$3,005,000
-53.7%
488,552
-21.0%
0.00%
-100.0%
Q3 2018$6,497,000
-44.6%
618,206
-22.7%
0.00%0.0%
Q2 2018$11,736,000
+2.9%
800,0000.0%0.00%0.0%
Q1 2018$11,400,000
+21.3%
800,0000.0%0.00%0.0%
Q4 2017$9,400,000800,0000.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders